Community-associated Escherichia coli harboring CTX-M β-lactamases from urine cultures from pediatric patients

Antimicrobial Agents and Chemotherapy

Volumn 56, Issue 4, 2012, Pages 2209-2210

  Woods, Krystina L ^a   Johnson, James R ^b   Padkowsky, Sofia ^c   Mariano, Noriel ^a   Colon Urban, Rita ^d   Hassanein, Mahmoud ^a   Wehbeh, Wehbeh ^a   Johnston, Brian D ^b   Clabots, Connie ^b   Zahid, Saadia ^a   Urban, Carl ^a  

^a NEW YORK HOSPITAL QUEENS   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c Universidad Iberoamericana (UNIBE)   (Dominican Republic)

^d STATE UNIVERSITY OF NEW YORK   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA LACTAM ANTIBIOTIC; BETA LACTAMASE CTX M; CEFTAZIDIME; CEFTRIAXONE; COTRIMOXAZOLE; LEVOFLOXACIN; MEROPENEM;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; BACTERIAL VIRULENCE; BACTERIUM ISOLATE; CHILD; CLINICAL ARTICLE; ENTEROBACTERIACEAE INFECTION; ESCHERICHIA COLI; EXTENDED SPECTRUM BETA LACTAMASE PRODUCING ENTEROBACTERIACEAE; FEMALE; GENOTYPE; HUMAN; IN VITRO STUDY; INFANT; LETTER; MALE; PHYLOGENY; PRESCHOOL CHILD; PRIORITY JOURNAL; URINE CULTURE;

BETA-LACTAMASES; CHILD; CHILD, PRESCHOOL; COMMUNITY-ACQUIRED INFECTIONS; ELECTROPHORESIS, GEL, PULSED-FIELD; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FEMALE; HUMANS; INFANT; MALE; MICROBIAL SENSITIVITY TESTS;

EID: 84863372742     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00003-12     Document Type: Letter

References (12)

1. Azap OK, et al. 2010. Risk factors for extended spectrum-β-lactamase positivity in uropathogenic Escherichia coli isolated from community-acquired urinary tract infections. Clin. Microb. Infect. 16:147-151.
2. Boyer-Mariotte S, et al. 2008. CTX-M-15-producing Escherichia coli in fatal neonatal meningitis: failure of empirical chemotherapy. J. Antimicrob. Chemother. 62:1472-1474.
3. Reference deleted.
4. Johnson JR, et al. 2009. Epidemic clonal groups of Escherichia coli as a cause of antimicrobial-resistant urinary tract infections in Canada, 2002 to 2004. Antimicrob. Agents Chemother. 53:2733-2739.
5. Johnson JR, Johnston B, Clabots C, Kuskowski MA, Castanheira M. 2010. Escherichia coli sequence type ST131 as the major cause of serious multidrug-resistant E. coli infections in the United States (2007). Clin. Infect. Dis. 51:286-294.
6. Nicolas-Chanoine M-H, et al. 2008. Intercontinental emergence of Escherichia coli clone O25:H4-ST131 producing CTX-M-15. J. Antimicrob. Chemother. 61:273-281.
7. Owens RC, Jr, et al. 2011. Community transmission in the United States of a CTX-M-15-producing sequence type ST131 Escherichia coli strain resulting in death. J. Clin. Microbiol. 49:3406-3408.
8. Pitout JD, Laupland KB. 2008. Extended-spectrum beta-lactamase-producing Enterobacteriaceae: an emerging public-health concern. Lancet Infect. Dis. 8:159-166. (Pubitemid 351249250)
9. Ramdani-Bouguessa N, et al. 2006. CTX-M-3 and CTX-M-15 extended-spectrum β-lactamases in isolates of Escherichia coli from a hospital in Algiers, Algeria. J. Clin. Microbiol. 44:4584-4586. (Pubitemid 44937102)
10. Reference deleted.
11. Tiruvury H, et al. 2012. Identification of CTX-M β-lactamases among Escherichia coli from the community in New York City. Diagn. Microbiol. Infect. Dis. 72:248-252.
12. Urban C, et al. 2010. Identification of CTX-M β-lactamases in Escherichia coli from hospitalized patients and residents of long-term care facilities. Diagn. Microbiol. Infect. Dis. 66:402-406.